{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:55:21Z","timestamp":1717235721417},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.thromres.2004.12.014","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T04:15:39Z","timestamp":1106712939000},"page":"293-300","source":"Crossref","is-referenced-by-count":5,"title":["Superior efficacy of clopidogrel plus acetylsalicylic acid compared with extended-release dipyridamole plus acetylsalicylic acid in preventing arterial thrombogenesis in healthy volunteers"],"prefix":"10.1016","volume":"116","author":[{"given":"Yves","family":"Cadroy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Thalamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjell","family":"Sakariassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Boneu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2004.12.014_bib1","doi-asserted-by":"crossref","first-page":"513S","DOI":"10.1378\/chest.126.3_suppl.513S","article-title":"Antithrombotic therapy for coronary artery disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Harrington","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2004.12.014_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"Suppl. 5","key":"10.1016\/j.thromres.2004.12.014_bib3","doi-asserted-by":"crossref","first-page":"470S","DOI":"10.1378\/chest.114.5_Supplement.470S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness, and side effects","volume":"114","author":"Patrono","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2004.12.014_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1661437","article-title":"Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity","volume":"55","author":"Gresele","year":"1986","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.12.014_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(85)91718-0","article-title":"Combining antiplatelet agents: potentiation between aspirin and dipyridamole","volume":"1","author":"Gresele","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.12.014_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.thromres.2004.12.014_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2004.12.014_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","article-title":"Identification and biological activity of the active metabolite of clopidogrel","volume":"84","author":"Savi","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.12.014_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/bbrc.2001.4816","article-title":"P2y(12), a new platelet ADP receptor, target of clopidogrel","volume":"283","author":"Savi","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.thromres.2004.12.014_bib10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.12.014_bib11","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1053\/euhj.2000.2474","article-title":"The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease","volume":"21","author":"Mehta","year":"2000","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2004.12.014_bib12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2004.12.014_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.12.014_bib14","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/01.CIR.98.22.2461","article-title":"Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates","volume":"98","author":"Harker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.12.014_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1055\/s-0037-1615238","article-title":"The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit","volume":"80","author":"Herbert","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.12.014_bib16","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1053\/euhj.1998.1042","article-title":"Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis","volume":"19","author":"Makkar","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2004.12.014_bib17","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/01.CIR.101.24.2823","article-title":"Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans","volume":"101","author":"Cadroy","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.12.014_bib18","doi-asserted-by":"crossref","DOI":"10.1159\/000083885","article-title":"Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers","author":"Caplain","year":"2005","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.thromres.2004.12.014_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0038-1642391","article-title":"HN-11500\u2014a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions","volume":"71","author":"Roald","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.12.014_bib20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1055\/s-0038-1642499","article-title":"Clopidogrel-A platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions","volume":"71","author":"Roald","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.12.014_bib21","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/01.ATV.19.5.1348","article-title":"Comparison of the antithrombotic effect of PEG-Hirudin and heparin in a human ex vivo model of arterial thrombosis","volume":"19","author":"Bossavy","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2004.12.014_bib22","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1161\/01.ATV.19.9.2269","article-title":"Antithrombotic efficacy of the vitamin K antagonist fluindione in a human ex vivo model of arterial thrombosis: effect of anticoagulation level and combination therapy with aspirin","volume":"19","author":"Bossavy","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2004.12.014_bib23","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1182\/blood.V92.5.1518","article-title":"A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans","volume":"92","author":"Bossavy","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.12.014_bib24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.ATV.10.2.276","article-title":"Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin","volume":"10","author":"Sakariassen","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.thromres.2004.12.014_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-0037-1614237","article-title":"A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis","volume":"79","author":"Bossavy","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.12.014_bib26","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","article-title":"Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases","volume":"91","author":"Fressinaud","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.12.014_bib27","first-page":"56802","article-title":"Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labelling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products [Docket no. 77N-094A]","volume":"63","author":"Department of Health and Human Services: Food and Drug Administration","year":"1998","journal-title":"Fed. Regist."},{"key":"10.1016\/j.thromres.2004.12.014_bib28","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2004.12.014_bib29","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"On behalf of the CURE (Clopidogrel in Unstable angina to prevent Recurrent events) Trial Investigators. Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.12.014_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.12.014_bib31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1055\/s-0038-1657594","article-title":"Thrombin, fibrin and platelets: a resonance loop in which von Willebrand factor is a necessary link","volume":"78","author":"Beguin","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.12.014_bib32","series-title":"Advances in cardiovascular engineering","first-page":"151","article-title":"Ex vivo models for studying thrombosis: special emphasis on shear rate dependent blood\u2013collagen interactions","author":"Sakariassen","year":"1992"},{"key":"10.1016\/j.thromres.2004.12.014_bib33","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1172\/JCI117014","article-title":"Increased platelet deposition on atherosclerotic coronary arteries","volume":"93","author":"van Zanten","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2004.12.014_bib34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.95.3.594","article-title":"Tissue factor modulates the thrombogenicity of human atherosclerotic plaques","volume":"95","author":"Toschi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.12.014_bib35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2125.1990.tb03763.x","article-title":"Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo","volume":"30","author":"M\u00fcller","year":"1990","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2004.12.014_bib36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/09537109777069","article-title":"Role of ADP and thromboxanes in human thrombus formation in ex vivo models","volume":"8","author":"Sakariassen","year":"1997","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2004.12.014_bib37","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/S0002-8703(98)70241-8","article-title":"Blood flow and antithrombotic drug effects","volume":"135","author":"Hanson","year":"1998","journal-title":"Am. Heart J."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804006577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804006577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T12:28:21Z","timestamp":1586089701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384804006577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0049384804006577"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.12.014","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}